News

At the Future Nutra Innovation Summit, SPINS' Scott Dicker presented data showing protein and performance nutrition account for 45% of total supplement growth, while sleep, cognitive health, reproductive health, and weight loss formulas have flattened or declined.

Live from the Future Nutra Innovation Summit, Cassie Evans, PhD, RD, explains what sets Helaina's effera human-identical lactoferrin apart in multiple aspects.

The inaugural Future Nutra Innovation Summit opened with organizers pitching a networking-first alternative to the traditional trade show, followed by an NSF presentation on certification failure rates and consumer trust that set a tone for the rest of the event.

Luigi Cappello joins CEO Tim Condron on Vitaquest's executive team; the company also recently expanded its probiotics manufacturing capacity.

The randomized, double-blind placebo-controlled study found laboratory safety markers remained within normal ranges across treatment and placebo groups.

This overview outlines the clinical background, consumer landscape, and technical developments shaping the gluten-free category.

As joint structure degrades, pain and mobility become problems. Certain supplement ingredients may help maintain joint integrity and forestall pain and poor function as one ages.

New research finds 40% of consumers still struggle with digestive upset and points formulators toward function-first messaging over ingredient-first claims.

The partnership pairs Oobli's non-GMO sweet proteins, which offer sugar-like taste but digest as protein, with education initiatives and a consumer-facing platform.

The new yeast-based nutrients, Amberferm Grow 288 and 289, are designed to raise packed cell volume yield and acidification activity in dairy culture production, without added capital investment.

Ahead of her keynote at The Outlook on Active Nutrition, Michelle Arent, USC's Olympic sports performance nutrition director, shares her rigorous supplement vetting process, industry gaps in usability, and a preview of her presentation.

In the eighth episode, Nicholas Saraceno examines how social media has reshaped where people get their health and supplement information, from AI-generated "wellness experts" running fabricated ads to registered dietitians and physicians building their own followings to counter it.

dsm-firmenich is directing formulators toward taste and flavor-masking technology earlier in medical nutrition product development, citing survey data on why patients stop taking oral nutritional supplements.

The deal will establish a global Citrus and Beverage Center of Excellence in Florida and follows Mane's recent moves in savory flavors and stevia-based sweeteners.

A new request for information, expert roundtable findings, and a transatlantic workshop signal FDA's renewed focus on plant-based drug products.

A 28-day evaluation of TriNutra’s 5% B'utyQuin scalp lotion reported reduced hair loss and modest density increases in 22 adults, adding early clinical data to a cosmetic ingredient formulators are positioning for scalp health claims.

Why do promising nutraceutical ingredients underperform in human trials? This piece explores how phenotype-based recruitment aligns participant biology with mechanism, reducing signal dilution and producing more commercially meaningful efficacy evidence.

The deal would add Twinlab, Reserveage, Metabolife, and Alvita Tea to cbdMD's wellness portfolio, moving through a court-supervised creditor proceeding rather than a conventional acquisition.

The panel closes by discussing which ingredient pairings show real biological synergy, whether brands are thinking about nutrient absorption competition, and why the budget-conscious end of the market may be the industry's most overlooked opportunity.

The comprehensive review synthesizes mechanistic and clinical evidence on the probiotic strain's role in enhancing non-heme iron absorption.

Congress has pushed back the 0.4 mg THC cap by one month, giving supplement brands additional time before the new hemp definition takes effect.

A 90-day trial of Arjuna Natural's Shoden ashwagandha extract found no clinically significant changes in liver, kidney, or metabolic markers among 62 healthy adults.

The private equity firm's agreement to buy Nature's Bounty, Nuun, Osteo Bi-Flex, and Gard from Nestlé signals continued consolidation in the vitamins, minerals, and supplements category as strategic buyers narrow their brand portfolios.

Franziska Weichmann, PhD, discusses the microcirculation, antioxidant, and gene-expression research behind Pycnogenol's effects on scalp and skin barrier health, ongoing mechanistic studies, and how the ingredient fits into combination formulas.

From effervescent powders to protein donuts, panelists discuss how brands are using format and flavor innovation, including unexpected soda-inspired flavors, to turn daily supplementation into something consumers look forward to.

Douglas Kalman, PhD, explains how to support GLP-1 user nutrition, previewing his upcoming session on formulating for muscle preservation at Outlook on Active Nutrition.

New preclinical research on Elissara by Monteloeder, SL, point to multiple mechanisms of action for the four-botanical ingredient, examining effects on DHT-related enzymes, cell proliferation, and oxidative stress.

A third round of independent laboratory testing found 4 more finished ubiquinol products containing only trace amounts of the labeled ingredient, bringing the running total of flagged products to two dozen since testing began in 2025.